Detalhe da pesquisa
1.
Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer.
N Engl J Med
; 362(22): 2053-65, 2010 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-20519679
2.
Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43.
Breast Cancer Res Treat
; 142(2): 415-21, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24202240
3.
A pilot study of long-acting octreotide for symptomatic malignant ascites.
Oncology
; 82(6): 315-20, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22572824
4.
Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
JAMA
; 295(23): 2742-51, 2006 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-16754728
5.
Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
JAMA
; 295(23): 2727-41, 2006 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-16754727
6.
Concurrent bevacizumab with a sequential regimen of doxorubicin and cyclophosphamide followed by docetaxel and capecitabine as neoadjuvant therapy for HER2- locally advanced breast cancer: a phase II trial of the NSABP Foundation Research Group.
Clin Breast Cancer
; 11(4): 228-34, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21684812
7.
Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial.
J Clin Oncol
; 29(9): 1110-6, 2011 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21300930
8.
CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphoma.
Int J Radiat Oncol Biol Phys
; 81(2): 476-82, 2011 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20800387
9.
Placebo-controlled trial to determine the effectiveness of a urea/lactic acid-based topical keratolytic agent for prevention of capecitabine-induced hand-foot syndrome: North Central Cancer Treatment Group Study N05C5.
J Clin Oncol
; 28(35): 5182-7, 2010 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21060036
10.
A phase II neoadjuvant trial of sequential nanoparticle albumin-bound paclitaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide in locally advanced breast cancer.
Clin Breast Cancer
; 10(1): 81-6, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20133263
11.
Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer.
Cancer Prev Res (Phila)
; 3(6): 696-706, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20404000
12.
Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.
J Clin Oncol
; 26(5): 778-85, 2008 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-18258986
13.
Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial.
J Clin Oncol
; 26(12): 1965-71, 2008 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18332472
14.
Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07.
J Clin Oncol
; 25(16): 2205-11, 2007 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17470850